Quarter Financials
Provention Bio, Inc. (PRVB)
$4.08
+0.18 (+4.62%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
|---|
| Net Income | -22 | -26 | -27 | -29 | -32 | -33 | -31 | -22 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -314 | -292 | -266 | -239 | -210 | -178 | -145 | -114 |
|---|
|
Year
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
|---|
| Capital Expenditure | - | -0 | - | -1 | -0 | -1 | - | - |
|---|
| Net PPE | 2 | 2 | 2 | 3 | 2 | 2 | 0 | - |
|---|
|
Year
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
|---|
| New Purchases | - | -16 | -4 | -12 | -4 | - | -39 | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|